Adrenomed

Website

Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. The company's products use biomarker-guided monoclonal antibody therapies, which offer causative and safe tr...

Healthcare
Hennigsdorf, Germany
Founded 2009
22 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$61.3M
Last Round
N/A
Investors
+10 other investors
View all 10 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Adrenomed's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required